Clinic reduces GA1 brain injury risk by 83% with therapies developed over 30 years

October 13, 2020

A new study summarizes over 30 years of clinical experience in the treatment and management of glutaric acidemia type 1 (GA1), a rare and potentially devastating metabolic disorder caused by variants in the GCDH gene. The study followed the clinical course of 168 individuals with GA1 who were born between 1973 and 2019 and originated from 26 states and 6 countries. Participants were divided into three cohorts based on timing of diagnosis and method of treatment. The study was a broad collaborative effort led by clinicians and researchers at the Clinic for Special Children (CSC) and will appear in Molecular Genetics and Metabolism. It establishes a safe and highly effective standard-of-care for the treatment of GA1, and should serve as a rich and valuable resource for dieticians, physicians, and GA1 families throughout the world for years to come.

Before the CSC's founding in 1989, 90% of infants and young children with GA1 suffered a catastrophic form of acute neurological degeneration. The brain injury of GA1 leaves children mute, wheelchair-dependent, and fully disabled by generalized dystonia, and often results in complications such as scoliosis, hip dislocation, pulmonary aspiration, chronic pain, and untimely death.

Today, with the benefit of early diagnosis, dietary therapy, and an effective hospital protocol, only 7% of children born with GA1 suffer brain injury. Specifically, state newborn screening coupled with strict dietary management reduces the risk of brain injury 14-fold, and uninjured children with GA1 have normal growth, motor development, and cognitive function. Overall, early diagnosis of GA1 with lysine-free, arginine-enriched metabolic formula and emergency IV infusions during the first two years of life is safe and effective - preventing over 90% of brain injuries. The need for dietary and emergency IV therapies beyond early childhood is uncertain at this time.
-end-
The research was conducted by a team including the study's first author Kevin A. Strauss from the Clinic for Special Children, Strasburg, PA, Department of Pediatrics, Penn Medicine - Lancaster General Hospital, Lancaster, PA and Departments of Pediatrics and Molecular, Cell & Cancer Biology, University of Massachusetts School of Medicine, Worcester, MA; senior author D. Holmes Morton from the Clinic for Special Children, Strasburg, PA, Department of Pediatrics, Penn Medicine - Lancaster General Hospital, Lancaster, PA, and Central Pennsylvania Clinic, Belleville, PA; Katie B. Williams, Lauren E. Bowser, Millie Young, Donna L. Robinson, Christine Hendrickson, Keturah Beiler, Erik G. Puffenberger, Karlla W. Brigatti from the Clinic for Special

Children, Strasburg, PA, Vincent J. Carson and Laura Poskitt from the Clinic for Special Children, Strasburg, PA and Department of Pediatrics, Penn Medicine - Lancaster General Hospital, Lancaster, PA, Cora M. Taylor and Barbara Haas-Givler from the Geisinger Autism & Developmental Medicine Institute, Lewisburg, PA, Jennifer Hailey from Wellspan Philhaven, Mount Gretna, PA, Stephanie Chopko from the Department of Pediatrics, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, and Freeman Miller from the Department of Orthopedic Surgery, Nemours/A.I. duPont Hospital for Children, Wilmington, DE.

This study was funded in part by a research grant from Nutricia North America, the manufacturer of Glutarade Junior and Glutarade Essential metabolic formula. No author received direct or indirect personal compensation from Nutricia or owns shares in the company. There are no other actual or potential conflicts of interest to declare.

The Clinic for Special Children (CSC) is a non-profit organization located in Strasburg, PA, which provides primary pediatric care and advanced laboratory services to those who live with genetic or other complex medical disorders. Founded in 1989, the organization provides services to over 1,050 individuals and is recognized as a worldleader in translational and precision medicine. The organization is primarily supported through community fundraising events and donations. For more information, please visit http://www.ClinicforSpecialChildren.org.

Clinic for Special Children

Related Brain Injury Articles from Brightsurf:

Using machine learning to predict pediatric brain injury
When newborn babies or children with heart or lung distress are struggling to survive, doctors often turn to a form of life support that uses artificial lungs.

A memory game could help us understand brain injury
A Boston University team created a memory game for mice in order to examine the function of two different brain areas that process information about the sensation of touch and the memory of previous events.

Clear signs of brain injury with severe COVID-19
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows.

Reducing dangerous swelling in traumatic brain injury
After a traumatic brain injury (TBI), the most harmful damage is caused by secondary swelling of the brain compressed inside the skull.

Can brain injury from boxing, MMA be measured?
For boxers and mixed martial arts (MMA) fighters, is there a safe level of exposure to head trauma?

Study: Brain injury common in domestic violence
Domestic violence survivors commonly suffer repeated blows to the head and strangulation, trauma that has lasting effects that should be widely recognized by advocates, health care providers, law enforcement and others who are in a position to help, according to the authors of a new study.

Which car crashes cause traumatic brain injury?
Motor vehicle crashes are one of the most common causes of TBI-related emergency room visits, hospitalizations and deaths.

Landmark study reveals no benefit to costly and risky brain cooling after brain injury
A landmark study, led by Monash University researchers, has definitively found that the practice of cooling the body and brain in patients who have recently received a severe traumatic brain injury, has no impact on the patient's long-term outcome.

Every cell has a story to tell in brain injury
Traumatic head injury can have widespread effects in the brain, but now scientists can look in real time at how head injury affects thousands of individual cells and genes simultaneously in mice.

Traumatic brain injury recovery via petri dish
Researchers in the University of Georgia's Regenerative Bioscience Center have succeeded in reproducing the effects of traumatic brain injury and stimulating recovery in neuron cells grown in a petri dish.

Read More: Brain Injury News and Brain Injury Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.